Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment

Clinical Rheumatology

Volumn 34, Issue 5, 2015, Pages 935-942

  Janta, Iustina ^a   Martínez Estupiñán, Lina ^a   Valor, Lara ^a   Montoro, María ^a   Baniandres Rodriguez, Ofelia ^a   Hernández Aragüés, Ignacio ^a   Bello, Natalia ^a   Hernández Flórez, Diana ^a   Hinojosa, Michelle ^a   Martínez Barrio, Julia ^a   Nieto González, Juan Carlos ^a   Ovalles Bonilla, Juan Gabriel ^a   González, Carlos Manuel ^a   López Longo, Francisco Javier ^a   Monteagudo, Indalecio ^a   Naredo, Esperanza ^a   Carreño, Luis ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Biologic therapy; Doppler; Psoriatic arthritis; Spondylarthropathies; Ultrasound

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; BIOLOGICAL PRODUCT; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTHRITIS, PSORIATIC; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DOPPLER FLOWMETRY; ECHOGRAPHY; ELBOW; FEMALE; FOOT; HAND JOINT; HUMAN; KNEE; MAINTENANCE CHEMOTHERAPY; MALE; MIDDLE AGED; PROCEDURES; SYNOVITIS; TENOSYNOVITIS; TREATMENT OUTCOME;

ADALIMUMAB; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; BIOLOGICAL PRODUCTS; CROSS-SECTIONAL STUDIES; ELBOW JOINT; ETANERCEPT; FEMALE; FOOT JOINTS; HAND JOINTS; HUMANS; INFLIXIMAB; KNEE JOINT; MAINTENANCE CHEMOTHERAPY; MALE; MIDDLE AGED; SYNOVITIS; TENOSYNOVITIS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 84940002837     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-015-2880-7     Document Type: Article

References (42)

1. Langley RG, Krueger GG, Griffiths CE (2005) Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 64(Suppl.2):ii18–23 [discussion ii4–5]
2. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl II):ii14–ii17
3. Gossec L, Smolen JS, Gaujoux-Viala C et al (2012) European League Against Rheumatism. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 71(1):4–12
4. Smolen JS, Breedveld FC, Eberl G et al (1995) Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 38:38–43
5. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–2291
6. Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285
7. Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS (2010) Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 69(8):1441–1447
8. Mumtaz A, Gallagher P, Kirby B et al (2011) Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis 70(2):272–7
9. Coates LC, Fransen J, Helliwell PS (2010) Defining minimal disease activity in psoriatic arthritis: a proposed target for treatment. Ann Rheum Dis 69:48–53
10. Coates LC, Helliwell PS (2010) Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data. Arthritis Care Res 62:965–969
11. Saad AA, Ashcroft DM, Watson KD, Symmons DP, Noyce PR, Hyrich KL (2010) BSRBR. Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 49(4):697–705
12. Heiberg MS, Kaufmann C, Rødevand E et al (2007) The comparative effectiveness of anti-TNF therapy and Methotrexate in patients with psoriatic arthritis: 6 months results from a longitudinal, observational, multicentre study. Ann Rheum Dis 66(8):1038–1042
13. Saber TP, Ng CT, Renard G et al (2010) Remission in psoriatic arthritis: is it possible and how can it be predicted? Arthritis Res Ther 12(3):R94
14. Husic R, Gretler J, Felber A et al (2013) Disparity between ultrasound and clinical findings in psoriatic arthritis. Ann Rheum Dis. doi:10.1136/annrheumdis-2012-203073, published on 5 June
15. Smolen JS, Landewé R, Breedveld FC et al (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73(3):492–509
16. Backhaus M, Kamradt T, Sandrock D et al (1999) Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging. Arthritis Rheum 42:1232–1245
17. Galluzco E, Lischi DM, Taglione E et al (2000) Sonographic analysis of the ankle in patients with psoriatic arthritis. Scand J Rheumatol 29:52–55
18. Balint PV, Kane D, Wilson H, Mclnnes IB, Sturrock RD (2002) Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 61:905–910
19. D’Agostino MA, Said-Nahal R, Hacquard-Bouder C, Brasseur JL, Dougados M, Breban M (2003) Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler. Arthritis Rheum 48:523–533
20. Kane D, Balint PV, Sturrock RD (2003) Ultrasonography is superior to clinical examination in the detection and localization of knee joint effusion in rheumatoid arthritis. J Rheumatol 30:966–971
21. Wakefield RJ, Green MJ, Marzo-Ortega H et al (2004) Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis 63:382–385
22. Szkudlarek M, Narvestad E, Klarlund M, Court-Payen M, Thomsen HS, Østergaard M (2004) Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination. Arthritis Rheum 50:2103–2112
23. Naredo E, Bonilla G, Gamero F, Uson J, Carmona L, Laffon A (2005) Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis 64:375–381
24. Alcalde M, Acebes JC, Cruz M, Gonzalez-Hombrado L, Herrero-Beaumont G, Sanchez-Pernaute O (2007) A sonographic enthesitis index (SEI) of lower limbs is a valuable tool in the assessment of ankylosing spondylitis. Ann Rheum Dis 66:1015–1019
25. Szkudlarek M, Court-Payen M, Strandberg C, Klarlund M, Klausen T, Østergaard M (2001) Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging. Arthritis Rheum 44:2018–2023
26. Naredo E, Möller I, Cruz A, Carmona L, Garrido J (2008) Power Doppler ultrasound monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid Arthritis. Arthritis Rheum 58:2248–2256
27. Andersen M, Ellegaard K, Hebsgaard JB et al (2014) Ultrasound colour Doppler is associated with synovial pathology in biopsies from hand joints in rheumatoid arthritis patients: a cross-sectional study. Ann Rheum Dis 73(4):678–683
28. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, the CASPAR Study Group (2006) Classification criteria for psoriatic arthritis development of new criteria from a large international study. Arthritis Rheum 54:2665–2673
29. Fernandez Sueiro JL, Juanola Roura X, de Dios Canete Crespillo J et al (2011) Consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in psoriatic arthritis. Reumatol Clin 7(3):179–188
30. Fredriksson T, Pettersson U (1978) Severe psoriasis-oral therapy with a new retinoid. Dermatologica 157(4):238–244
31. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A et al (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62:127–132
32. Rudwaleit M, van der Heijde D, Landewé R et al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25–31
33. Rudwaleit M, van der Heijde D, Landewé R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777–783
34. Naredo E, D'Agostino MA, Wakefield RJ et al (2013) OMERACT Ultrasound Task Force. Reliability of a consensus-based ultrasound score for tenosynovitis in rheumatoid arthritis. Ann Rheum Dis 72(8):1328–1334
35. Wakefield RJ, Balint PV, Szkudlarek M et al (2005) OMERACT 7 Special Interest Group. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 32(12):2485–2487
36. Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS, Østergaard M (2003) Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum 48(4):955–962
37. Saleem B, Keen H, Goeb V et al (2010) Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped? Ann Rheum Dis 69:1636–1642
38. Klarenbeek NB, van der Kooij SM, Güler-Yüksel M et al (2011) Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study. Ann Rheum Dis 70:315–319
39. van der Maas A, Kievit W, van den Bemt BJ, van den Hoogen FH, van Riel PL, den Broeder AA (2012) Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low diseaseactivity and stable treatment: an observational cohort study. Ann Rheum Dis 71:1849–1854
40. Cantini F, Niccoli L, Cassarà E, Kaloudi O, Nannini C (2012) Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study. Biologics 6:201–206
41. Araujo EG, Finzel S, Englbrecht M et al (2013) High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-204229
42. Freeston JE, Coates LC, Nam JL et al (2014) Is there subclinical synovitis in early psoriatic arthritis? A clinical comparison with gray-scale and power Doppler ultrasound. Arthritis Care Res (Hoboken) 66(3):432–439